<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Chiomenti - Le Fonti New Pharma Italy</title>
	<atom:link href="https://www.newpharmaitaly.it/tag/chiomenti/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/tag/chiomenti/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Sat, 01 Aug 2020 18:55:45 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.newpharmaitaly.it/wp-content/uploads/2022/12/cropped-favicon-new-pharma-italy-32x32.jpg</url>
	<title>Chiomenti - Le Fonti New Pharma Italy</title>
	<link>https://www.newpharmaitaly.it/tag/chiomenti/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Vittoria in rimonta per la Roma, contro la Juve finisce 3-1 </title>
		<link>https://www.newpharmaitaly.it/vittoria-in-rimonta-per-la-roma-contro-la-juve-finisce-3-1/</link>
					<comments>https://www.newpharmaitaly.it/vittoria-in-rimonta-per-la-roma-contro-la-juve-finisce-3-1/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Sat, 01 Aug 2020 18:55:45 +0000</pubDate>
				<category><![CDATA[Attualità]]></category>
		<category><![CDATA[banking]]></category>
		<category><![CDATA[cartolarizzazione]]></category>
		<category><![CDATA[Chiomenti]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/sport/2020/08/01/calcio-serie-roma-vittoria-rimonta-allo-stadium-contro-juve-finisce_JWxomJxe4ZqEdsX3AmO5zJ.html</guid>

					<description><![CDATA[<p>La Roma chiude nel migliore dei modi il campionato conquistando una vittoria di prestigio in trasferta contro la Juventus campione d’Italia. Allo Stadium finisce 3-1 in favore dei giallorossi bravi a ribaltare una gara cominciata male per il gol di Higuain...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/vittoria-in-rimonta-per-la-roma-contro-la-juve-finisce-3-1/">Vittoria in rimonta per la Roma, contro la Juve finisce 3-1 </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/vittoria-in-rimonta-per-la-roma-contro-la-juve-finisce-3-1/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Fase 3: Negri (Forever Living), &#8216;serve il lavoro e la risposta è il network marketing&#8217; </title>
		<link>https://www.newpharmaitaly.it/fase-3-negri-forever-living-serve-il-lavoro-e-la-risposta-e-il-network-marketing/</link>
					<comments>https://www.newpharmaitaly.it/fase-3-negri-forever-living-serve-il-lavoro-e-la-risposta-e-il-network-marketing/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Thu, 23 Jul 2020 22:19:26 +0000</pubDate>
				<category><![CDATA[Attualità]]></category>
		<category><![CDATA[cartolarizzazione]]></category>
		<category><![CDATA[Chiomenti]]></category>
		<category><![CDATA[clifford chance]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/soldi/economia/2020/07/24/fase-negri-forever-living-serve-lavoro-risposta-network-marketing_9nVvwYPErIFY0oOIUBT6cL.html</guid>

					<description><![CDATA[<p>L'esperienza ci insegna che in momenti come questi quello che serve è il lavoro e il network marketing è la risposta, in quanto si presta molto bene alla possibilità per ogni persona, in momenti di emergenza ma anche nella normalità, di...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/fase-3-negri-forever-living-serve-il-lavoro-e-la-risposta-e-il-network-marketing/">Fase 3: Negri (Forever Living), &#8216;serve il lavoro e la risposta è il network marketing&#8217; </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/fase-3-negri-forever-living-serve-il-lavoro-e-la-risposta-e-il-network-marketing/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Legge elettorale, fonti Iv: &#8220;Pd e M5S accelerano su testo che non ha maggioranza&#8221; </title>
		<link>https://www.newpharmaitaly.it/legge-elettorale-fonti-iv-pd-e-m5s-accelerano-su-testo-che-non-ha-maggioranza/</link>
					<comments>https://www.newpharmaitaly.it/legge-elettorale-fonti-iv-pd-e-m5s-accelerano-su-testo-che-non-ha-maggioranza/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Mon, 20 Jul 2020 15:44:14 +0000</pubDate>
				<category><![CDATA[Attualità]]></category>
		<category><![CDATA[acquisizione]]></category>
		<category><![CDATA[Alten]]></category>
		<category><![CDATA[Chiomenti]]></category>
		<category><![CDATA[legance]]></category>
		<category><![CDATA[SDG Group]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/fatti/politica/2020/07/20/elettorale-fonti-accelerano-testo-che-non-maggioranza_fwhZ1c4wMfaRAnHsRWUFIP.html</guid>

					<description><![CDATA[<p>Sulla legge elettorale fonti di Italia viva fanno sapere che in questo momento non c'è una maggioranza sul testo base su cui Pd e M5S stanno accelerando. Due partiti della maggioranza, viene rilevato, non lo condividono e chi dice che non...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/legge-elettorale-fonti-iv-pd-e-m5s-accelerano-su-testo-che-non-ha-maggioranza/">Legge elettorale, fonti Iv: &#8220;Pd e M5S accelerano su testo che non ha maggioranza&#8221; </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/legge-elettorale-fonti-iv-pd-e-m5s-accelerano-su-testo-che-non-ha-maggioranza/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>RareCyte® announces the Orion™ spatial biology platform with breakthrough technology for same-day highly multiplexed tissue analysis </title>
		<link>https://www.newpharmaitaly.it/rarecyte-announces-the-orion-spatial-biology-platform-with-breakthrough-technology-for-same-day-highly-multiplexed-tissue-analysis/</link>
					<comments>https://www.newpharmaitaly.it/rarecyte-announces-the-orion-spatial-biology-platform-with-breakthrough-technology-for-same-day-highly-multiplexed-tissue-analysis/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Wed, 15 Jul 2020 22:08:02 +0000</pubDate>
				<category><![CDATA[Immedia press]]></category>
		<category><![CDATA[acquisizione]]></category>
		<category><![CDATA[Chiomenti]]></category>
		<category><![CDATA[gatti pavesi bianchi]]></category>
		<category><![CDATA[optotec]]></category>
		<category><![CDATA[sterlite technologies]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/immediapress/chimica-e-farmacia/2020/07/16/rarecyte-announces-the-orion-spatial-biology-platform-with-breakthrough-technology-for-same-day-highly-multiplexed-tissue-analysis_ta5E6Uv6LUjRGE05WlzyhP.html</guid>

					<description><![CDATA[<p>A complete platform of instrumentation, software, and reagents for rapid fluorescence staining and 21-channel whole-slide imaging SEATTLE, July 16, 2020 /PRNewswire/ -- RareCyte, Inc., a company focused on providing Precision Biology™ solutions for life sciences, announced today the Orion spatial biology analysis...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/rarecyte-announces-the-orion-spatial-biology-platform-with-breakthrough-technology-for-same-day-highly-multiplexed-tissue-analysis/">RareCyte® announces the Orion™ spatial biology platform with breakthrough technology for same-day highly multiplexed tissue analysis </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/rarecyte-announces-the-orion-spatial-biology-platform-with-breakthrough-technology-for-same-day-highly-multiplexed-tissue-analysis/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Semplificazioni, stop bandi per opere fino a 5 milioni </title>
		<link>https://www.newpharmaitaly.it/semplificazioni-stop-bandi-per-opere-fino-a-5-milioni/</link>
					<comments>https://www.newpharmaitaly.it/semplificazioni-stop-bandi-per-opere-fino-a-5-milioni/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Mon, 06 Jul 2020 22:57:38 +0000</pubDate>
				<category><![CDATA[Attualità]]></category>
		<category><![CDATA[acquisizione]]></category>
		<category><![CDATA[Ashurst]]></category>
		<category><![CDATA[Chiomenti]]></category>
		<category><![CDATA[Franco Vigliano]]></category>
		<category><![CDATA[norton rose]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/fatti/politica/2020/07/07/semplificazioni-conte-bando-gara-mila-mln-euro_IlKn0oKkAjzZoJ0bIcILYM.html</guid>

					<description><![CDATA[<p>"Gli appalti saranno più veloci. Niente gara sotto i 150 mila euro; la soglia per l'affidamento diretto passa da 40 mila a 150. Da oggi le pubbliche amministrazioni saranno in grado di far partire le opere. Fino a 5 milioni non...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/semplificazioni-stop-bandi-per-opere-fino-a-5-milioni/">Semplificazioni, stop bandi per opere fino a 5 milioni </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/semplificazioni-stop-bandi-per-opere-fino-a-5-milioni/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Enrico Vanzina: &#8220;&#8216;Sotto il sole di Riccione&#8217; omaggio a Carlo&#8221; </title>
		<link>https://www.newpharmaitaly.it/enrico-vanzina-sotto-il-sole-di-riccione-omaggio-a-carlo/</link>
					<comments>https://www.newpharmaitaly.it/enrico-vanzina-sotto-il-sole-di-riccione-omaggio-a-carlo/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Sat, 27 Jun 2020 06:24:16 +0000</pubDate>
				<category><![CDATA[Attualità]]></category>
		<category><![CDATA[cartolarizzazione]]></category>
		<category><![CDATA[Chiomenti]]></category>
		<category><![CDATA[clifford chance]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/intrattenimento/spettacolo/2020/06/27/enrico-vanzina-sotto-sole-riccione-omaggio-carlo_Jh43hoBxfIywl3mRndiUeK.html</guid>

					<description><![CDATA[<p>(Adnkronos/Cinematografo.it) - Da 'Sapore di mare, che hai sulla pelle, che hai sulle labbra' a 'Sotto il sole, sotto il sole di Riccione, di Riccione quasi quasi mi pento e non ci penso più', il passo è breve. Anche se Enrico...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/enrico-vanzina-sotto-il-sole-di-riccione-omaggio-a-carlo/">Enrico Vanzina: &#8220;&#8216;Sotto il sole di Riccione&#8217; omaggio a Carlo&#8221; </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/enrico-vanzina-sotto-il-sole-di-riccione-omaggio-a-carlo/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>G7, Speranza: &#8220;Preoccupa trend contagio nel mondo&#8221; </title>
		<link>https://www.newpharmaitaly.it/g7-speranza-preoccupa-trend-contagio-nel-mondo/</link>
					<comments>https://www.newpharmaitaly.it/g7-speranza-preoccupa-trend-contagio-nel-mondo/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Fri, 26 Jun 2020 11:07:48 +0000</pubDate>
				<category><![CDATA[Attualità]]></category>
		<category><![CDATA[acquisizione]]></category>
		<category><![CDATA[Chiomenti]]></category>
		<category><![CDATA[GOP]]></category>
		<category><![CDATA[rbs]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/fatti/cronaca/2020/06/26/coronavirus-speranza-preoccupazione-per-trend-contagio-nel-mondo_vmzCuipM8kRLKkhDWTCTCL.html</guid>

					<description><![CDATA[<p>"Preoccupazione per l'andamento del contagio nel mondo" è stata espressa dal ministro della Salute, Roberto Speranza, che ha partecipato alla teleconferenza dei ministri della Salute del G7.  "Soltanto insieme usciremo da questa battaglia" contro Covid-19, ha commentato Speranza al termine della...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/g7-speranza-preoccupa-trend-contagio-nel-mondo/">G7, Speranza: &#8220;Preoccupa trend contagio nel mondo&#8221; </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/g7-speranza-preoccupa-trend-contagio-nel-mondo/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>OKEx Announces Launch of Its Beacon Program &#8211; Mentorship and Masterclass Series for the European Region </title>
		<link>https://www.newpharmaitaly.it/okex-announces-launch-of-its-beacon-program-mentorship-and-masterclass-series-for-the-european-region/</link>
					<comments>https://www.newpharmaitaly.it/okex-announces-launch-of-its-beacon-program-mentorship-and-masterclass-series-for-the-european-region/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Wed, 27 May 2020 07:13:17 +0000</pubDate>
				<category><![CDATA[Immedia press]]></category>
		<category><![CDATA[Antonio Coletti]]></category>
		<category><![CDATA[bond]]></category>
		<category><![CDATA[capital markets]]></category>
		<category><![CDATA[Chiomenti]]></category>
		<category><![CDATA[emissione obbligazionaria]]></category>
		<category><![CDATA[latham & watkins]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/immediapress/2020/05/27/okex-announces-launch-its-beacon-program-mentorship-and-masterclass-series-for-the-european-region_8B5Tb0Y0Q4VlboC70bEuHK.html</guid>

					<description><![CDATA[<p>VALLETTA, Malta, May 27, 2020 /PRNewswire/ -- OKEx (www.okex.com), the world's largest cryptocurrency spot and derivatives exchange, announces the launch of its OKEx Beacon Program, a Masterclass and Mentorship series specifically for the European region, today. The program consists of a combination...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/okex-announces-launch-of-its-beacon-program-mentorship-and-masterclass-series-for-the-european-region/">OKEx Announces Launch of Its Beacon Program &#8211; Mentorship and Masterclass Series for the European Region </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/okex-announces-launch-of-its-beacon-program-mentorship-and-masterclass-series-for-the-european-region/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
